Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shiv Verma

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Cancers|October 16, 2025
EZH2 Dysregulation and Its Oncogenic Role in Human CancersShiv Verma, Nikita Goyal, Suhani Goyal, et al.
Cancer Letters|August 14, 2025
Chimeric antigen receptor-engineered (CAR)-T cell therapy for metastatic prostate cancerLeah Tharian, Shiv Verma, Daniel Feinberg, et al.
Frontiers in Genetics|April 12, 2019
Differentially Expressed Genes and Molecular Pathways in an Autochthonous Mouse Prostate Cancer ModelShiv Verma, Sanjeev Shukla, Mitali Pandey, et al.
Plant Molecular Biology|November 12, 2010
Functional characterization of four APETALA2-family genes (RAP2.6, RAP2.6L, DREB19 and DREB26) in ArabidopsisSowmya Krishnaswamy, Shiv Verma, Muhammad H Rahman, et al.
Plos One|November 23, 2019
Integrated analysis of miRNA landscape and cellular networking pathways in stage-specific prostate cancerShiv Verma, Mitali Pandey, Girish C Shukla, et al.
The Prostate|July 13, 2022
Increased cytokine gene expression and cognition risk associated with androgen deprivation therapyShiv Verma, Prem Prakash Kushwaha, Eswar Shankar, et al.
The Prostate|July 10, 2025
miRNAs Regulating GSTP1 as Potential Diagnostic Biomarkers in Prostate CancerShiv Verma, Cheryl L Thompson, Pingfu Fu, et al.
Journal of Biosciences|February 24, 2012
Recent advances in development of marker-free transgenic plants: regulation and biosafety concernNarendra Tuteja, Shiv Verma, Ranjan Kumar Sahoo, et al.
Cancers|January 23, 2024
Melanoma Antigen Family A (MAGE A) as Promising Biomarkers and Therapeutic Targets in Bladder CancerShiv Verma, Diya Swain, Prem Prakash Kushwaha, et al.
JBMR Plus|May 12, 2021
Comparable Initial Engagement of Intracellular Signaling Pathways by Parathyroid Hormone Receptor Ligands Teriparatide, Abaloparatide, and Long-Acting PTHTadatoshi Sato, Shiv Verma, Ashok Khatri, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Cancers|October 16, 2025
EZH2 Dysregulation and Its Oncogenic Role in Human CancersShiv Verma, Nikita Goyal, Suhani Goyal, et al.
Cancer Letters|August 14, 2025
Chimeric antigen receptor-engineered (CAR)-T cell therapy for metastatic prostate cancerLeah Tharian, Shiv Verma, Daniel Feinberg, et al.
Frontiers in Genetics|April 12, 2019
Differentially Expressed Genes and Molecular Pathways in an Autochthonous Mouse Prostate Cancer ModelShiv Verma, Sanjeev Shukla, Mitali Pandey, et al.
Plant Molecular Biology|November 12, 2010
Functional characterization of four APETALA2-family genes (RAP2.6, RAP2.6L, DREB19 and DREB26) in ArabidopsisSowmya Krishnaswamy, Shiv Verma, Muhammad H Rahman, et al.
Plos One|November 23, 2019
Integrated analysis of miRNA landscape and cellular networking pathways in stage-specific prostate cancerShiv Verma, Mitali Pandey, Girish C Shukla, et al.
The Prostate|July 13, 2022
Increased cytokine gene expression and cognition risk associated with androgen deprivation therapyShiv Verma, Prem Prakash Kushwaha, Eswar Shankar, et al.
The Prostate|July 10, 2025
miRNAs Regulating GSTP1 as Potential Diagnostic Biomarkers in Prostate CancerShiv Verma, Cheryl L Thompson, Pingfu Fu, et al.
Journal of Biosciences|February 24, 2012
Recent advances in development of marker-free transgenic plants: regulation and biosafety concernNarendra Tuteja, Shiv Verma, Ranjan Kumar Sahoo, et al.
Cancers|January 23, 2024
Melanoma Antigen Family A (MAGE A) as Promising Biomarkers and Therapeutic Targets in Bladder CancerShiv Verma, Diya Swain, Prem Prakash Kushwaha, et al.
JBMR Plus|May 12, 2021
Comparable Initial Engagement of Intracellular Signaling Pathways by Parathyroid Hormone Receptor Ligands Teriparatide, Abaloparatide, and Long-Acting PTHTadatoshi Sato, Shiv Verma, Ashok Khatri, et al.
Pageof 4